Imagine the Combination of Challenge and Solution

I know about a company that does that perfectly. I know about a company that does that perfectly. [Healwell AI]( Dear Investor, This has all the ingredients of a great investment opportunity... Start with an aging population that does not have a great reputation for following the healthiest diets or exercise plans. Throw in an overburdened healthcare system that strains to keep up with the needs of that aging population and its growing need for earlier detection, and better treatment options, for a wide range of medical and health issues. Finally, add significant cutbacks in funding sources for clinics, hospitals, even doctors' offices, and what do you have? Answer: one monster healthcare crisis. Second scenario: A new technological development is running rampant through the world's economy. It is literally changing the face of how we do business, from deep fake videos to content created by bits and bytes. There is the fear that millions of people will lose their jobs and that there is no answer to the cybersecurity risk this development offers. Yes, the monster of AI – Artificial Intelligence – walks among us today, often hidden from view, but nonetheless creating panic in boardrooms, in laboratories, and in offices and homes worldwide. My name is Tim Collins, and I am the Editor of Streetlight Confidential. My job is simple: find companies that solve the challenges of a majority of people and offer positive investment opportunities. Daily, I hunt for and research companies that I think offer those opportunities for my readers. One such company caught my eye the other day. My research shows that they enjoyed a 292% increase in share value in a period of just fewer than 120 days. What is their magic? They learned how to tame the monster that is AI and use it to help the healthcare industry with early detection, diagnosis, treatment, and in some cases even cure, for a wide range of medical issues that an aging population faces. And we're talking about an industry – healthcare – that will grow to more than $10 trillion – that's $10,000,000,000,000.00 – in fewer than 10 years! Now, I don't get this excited about just any old company that I investigate, but I have to tell you, I think this is one that you should seriously consider as an addition to your portfolio. Here's my invitation to you, as a serious investor: [click here right now]( and check out more on this story. (It's one of the featured picks I have for subscribers to Streetlight Confidential.) You'll be happy you [clicked!]( Sincerely, Tim Collins Sr. Editor, Streetlight Confidential P.S.: In a recent period of less than 4 months, this company I mentioned saw an increase in share value of 292%. So, yes, I really do think you should [click here]( and discover what I found out... [Download Free Report]( --------------------------------------------------------------- IMPORTANT NOTICE AND DISCLAIMER: All investments are subject to risk, which must be considered on an individual basis before making any investment decision. This paid advertisement includes a stock profile of HEALWELL AI (OTCQX: HWAIF). Streetlight Confidential is an investment newsletter being advertised herein. This paid advertisement is intended solely for information and educational purposes and is not to be construed under any circumstances as an offer to sell or a solicitation of an offer to purchase any securities of HEALWELL AI (OTCQX: HWAIF). In an effort to enhance public awareness, HEALWELL AI (OTCQX: HWAIF) is the sole source of funds for a budget of approximately $1,001,180 to cover the costs associated with creating, printing and distribution of this advertisement. Streetlight Confidential was paid $45,000 as a research fee. In addition, Streetlight Confidential may receive subscription revenue in the future from new subscribers as a result of this advertisement for its newsletter. The advertising agencies will retain any excess sums after all expenses are paid. While this advertisement is being disseminated and for a period of not less than 90 days thereafter, Streetlight Confidential, the advertising agencies, and their respective officers, principals, or affiliates will not trade in securities of HEALWELL AI (OTCQX: HWAIF). If successful, this advertisement will increase investor and market awareness of HEALWELL AI (OTCQX: HWAIF) and its securities, which may result in an increased number of shareholders owning and trading the securities, increased trading volume, and possibly an increase in share price, which may be temporary. This advertisement, the advertising agencies and Streetlight Confidential do not purport to provide a complete analysis of HEALWELL AI (OTCQX: HWAIF) or its financial position. They are not, and do not purport to be, broker-dealers or registered investment advisors. This advertisement is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular investor. Any investment should be made only after consulting a registered broker-dealer or registered investment advisor or, at a minimum, doing your own research if you do not utilize an investment professional to make decisions on what securities to buy and sell, and only after reviewing the financial statements and other pertinent publicly-available information about HEALWELL AI (OTCQX: HWAIF). Further, readers are specifically urged to read and carefully consider the Risk Factors identified and discussed in the latest HEALWELL AI (OTCQX: HWAIF) Annual Information Form dated April 1, 2024 which is available at www.sedarplus.com. Investing in microcap securities such as HEALWELL AI (OTCQX: HWAIF) is speculative and carries a high degree of risk. Past performance may not be indicative of and does not guarantee future results. This advertisement is based exclusively on information generally available to the public and does not contain any material, non-public information. The information on which it is based is believed to be reliable. Nevertheless, the advertising agencies and Streetlight Confidential cannot guarantee the accuracy or completeness of the information and are not responsible for any errors or omissions. This advertisement contains “forward-looking information” and “forward-looking statements within the meaning of applicable securities laws, which are based on assumptions, estimates and projections as of the date of this advertisement, including statements regarding expected growth of HEALWELL AI (OTCQX: HWAIF) and/or its industry, potential synergies between HEALWELL AI's (OTCQX: HWAIF) various product and service offerings, and HEALWELL AI's (OTCQX: HWAIF) intention to leverage AI capabilities and expertise to expand and grow. Such statements and information are often, but not always, accompanied by words or phrases such as “future”, “potential”, “expect”, “intend”, “plan”, “anticipate”, “continues to”, “is becoming”, or variations of such words and phrases or statements that certain future conditions, actions, events or results “will”, “may”, “could”, “would”, “should”, “might” or “can” be taken, occur or be achieved, or the negative of any of these terms. The advertising agencies and Streetlight Confidential note that statements contained herein that look forward in time, which include everything other than historical information, involve risks and uncertainties that may affect HEALWELL AI (OTCQX: HWAIF) actual results of operations. Factors that could cause actual results to vary include: the size and growth of the market for HEALWELL AI (OTCQX: HWAIF) products and/or services, the company's ability to fund its capital requirements in the near term and long term, federal, state and provincial regulatory issues in the jurisdictions where the company operates or intends in the future to operate, pricing pressures; HEALWELL AI (OTCQX: HWAIF) ability to identify potential M&A partners and acquisition targets and successfully complete accretive transactions; HEALWELL AI (OTCQX: HWAIF) ability to successfully integrate its acquisition targets; developments in AI, data management, clinical research and other industries in which HEALWELL AI (OTCQX: HWAIF) operates; trends in customer growth; the need for increasingly innovating products and services; competition in the industry; customers adopting and using new technologies and services as expected; new technologies functioning as expected; anticipated development timelines for new products and services, or to expand existing product and service offerings into new jurisdictions; etc. There can be no assurance that forward looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. The advertising agencies and Streetlight Confidential disclaim any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, or to explain any material difference between subsequent actual events and such forward-looking statements, except to the extent required by applicable law. This advertisement contains future-oriented financial information and financial outlook information (collectively, “FOFI”) about HEALWELL AI's (OTCQX: HWAIF) expected increase in revenue, cash flow, profitability, profit margins, etc., all of which are subject to the same assumptions, risk factors, limitations, and qualifications as set out in the above paragraphs. The actual financial results of HEALWELL AI (OTCQX: HWAIF) may vary from the amounts set out herein and such variation may be material. The advertising agencies and Streetlight Confidential believe that the FOFI has been prepared on a reasonable basis, reflecting management's best estimates and judgments. However, because this information is subjective and subject to numerous risks, it should not be relied on as necessarily indicative of future results. Except as required by applicable securities laws, the advertising agencies and Streetlight Confidential undertake no obligation to update such FOFI. FOFI contained in this news release was made as of the date hereof and was provided for the purpose of providing further information about HEALWELL AI's (OTCQX: HWAIF) anticipated future business operations. Readers are cautioned that the FOFI contained in this news release should not be used for purposes other than for which it is disclosed herein. Streetlight Confidential is the publisher's trademark. All trademarks used in this advertisement other than Streetlight Confidential are the property of their respective trademark holders and no endorsement by such owners of the contents of this advertisement is made or implied. The advertising agencies and Streetlight Confidential are not affiliated, connected, or associated with, and are not sponsored, approved, or originated by, the trademark holders unless otherwise stated. No claim is made to any rights in any third-party trademarks. --------------------------------------------------------------- IMPORTANT NOTICE AND DISCLAIMER Pro Trading Research, LLC ("PTR"), the owner of this website (the "Website"), cannot guarantee the accuracy or completeness of the information contained in any article, email, newsletter, or other publication posted on or viewed in connection with this website (the "Publications"). The author or authors of those Publications are solely responsible for their contents. PTR has not done any research or due diligence into the markets, industries, or companies which may appear or be mentioned in the Publications. PTR will NOT be liable for any loss or damage caused by a reader's reliance on information posted on the Website or contained in the Publications. FOR EDUCATIONAL AND INFORMATIONAL PURPOSES ONLY; NOT INVESTMENT ADVICE. This Website and the Publications are for educational and informational purposes only. This Website and the Publications do not purport to be a complete analysis of any company's financial position. This Website, the Publications or any statements made in the Publications are not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular individual. This Website or the statements made in the Publications should NOT be relied upon for purposes of transacting in any securities posted on the Website or mentioned in the Publications, nor should they be construed as a personalized recommendation to you to buy, sell, or hold any position in any security posted on this Website or mentioned in any Publications. SUBSTANTIAL RISK IN INVESTMENT. Any individual who chooses to invest in any securities including those mentioned in the Publications should do so with caution. Investing or transacting in securities involves substantial risk; you may lose some, all, or possibly more than your original investment. Readers bear responsibility for their own investment research and decisions and should review all investment decisions with a licensed or registered investment professional. NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER Neither PTR nor any of its respective owners or employees are registered or licensed as a securities broker-dealer, broker, an investment advisor, or an investment advisor representative with the U.S. Securities and Exchange Commission (SEC), any state securities regulatory authority, or any self-regulatory organization. To more fully understand our Website, please review our full disclaimer located at: [( DISCLAIMER: ProTrading Research is strictly a research publishing firm and much of the information we publish in email and our various websites are obtained from sources we believe to be reliable. You should know that accuracy can never be guaranteed. We do not design our content to meet your personal situation & you need to know we are absolutely not financial advisors and we never, under any circumstance give our users personalized advice. Every single opinion we express herein are those of the publisher and are subject to change without notice. Published content may become outdated and there is no obligation to update any such information. This communication includes advertising material and PAID ADVERTISEMENTS provided to our customers. Stocks and options trading have large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the stocks and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell stocks or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed in this report. The past performance of any trading system or methodology is not necessarily indicative of future results. All trades, patterns, charts, systems, etc., discussed in this report are for illustrative purposes only and not to be construed as specific advisory recommendations. Information contained in this correspondence is intended for informational purposes only and was obtained from sources believed to be reliable. Information is in no way guaranteed. No guarantee of any kind is implied or possible where projections of future conditions are attempted. Sponsored emails, like this in ProTrading Research or our other publications, contain paid advertisements and don't necessarily endorse or recommend it to you or any investor. Neither the company nor our affiliates bear responsibility or control over the content of the advertisement and the product or service offered. Proceed at your own risk. [Privacy Policy]( If you wish to contact us, please do not reply to this message but instead e-mail us at info@em.protradingresearch.com. Replies to this message may not be read or responded to. We are unable to respond to emails and phone calls requesting personal financial advice. Sponsored emails, like this in ProTrading Research or our other publications, contain paid advertisements and don't necessarily endorse or recommend it to you or any investor. Neither the company nor our affiliates bear responsibility or control over the content of the advertisement and the product or service offered. Proceed at your own risk. If you wish to contact us, please do not reply to this message but instead e-mail us at info@em.protradingresearch.com. Replies to this message may not be read or responded to. We are unable to respond to emails and phone calls requesting personal financial advice. At ProTrading Research, it's our mission to create and provide a community that helps you live a more lucrative and enriched life. When ProTrading Research was established a few years back, we wanted to make the community an inclusive, welcoming table where everyone can come to find investment trends! Over the years, and over 100 thousand combined followers across our social media platforms, we will always aim to get better at what we do every single day! In addition, our primary focus is on our relationship with you. This way every time you decide to visit one of our properties or read one of our relevant articles, you end up getting an idea that takes your investment portfolio to the next level. We particularly appreciate when our following provides feedback via testimonials, reviews, and comments left on our site or social media accounts. Because with that feedback, we can use it to make your next investment or stock purchase even better than the last! Since we put so much effort into the relationship with you, we hope that any time spent with us is exactly the way you hoped it would be. Because by choosing to go with ProTrading Research, it's our promise that we provide a community you will love for years and years to come. Now, as much as we care about helping you make the right investments, we also care about your privacy. At ProTrading Research transparency and the use of data are important and we would like to be as explicit as we can about the use of data collected through our platforms. [ProTradingResearch.com]( is owned and operated by ProTrading Research, LLC. We're committed to the right of your privacy and strive to provide a safe and secure user experience. Our Privacy Policy explains how we collect, store and use personal information, provided by you on our website. What Information Do We Collect? When you visit our Web site you may provide us with two types of information: personal information you knowingly choose to disclose that is collected on an individual basis and Web site use information collected on an aggregate basis as you and others browse our Web site following all compliance standards. For example, you may need to provide the following information: - Name - Website URL information - Email address - Home and business phone number In addition to providing the foregoing information, if you choose to correspond further with us through email, we may retain the content of your email messages together with your email address and our responses securely within our systems. We provide the same protections for these electronic communications that we employ in the maintenance of information received by mail and telephone. It also explains important information that ensures we won't abuse the information that you provide to us in good faith. By accessing and using our website, you can trust that what you want to be kept private, will be kept private. If at any time, you would like to read our Privacy Policy and get a better understanding of your rights and liabilities under the law. Feel free to visit our site, find the privacy policy in the footer and read it. If there is something you are concerned about or wish to get more clarity on, please let us know by contacting us at info@em.protradingresearch.com. The Privacy Policy also informs you of how to notify us to stop using your personal information. If you wish to view our official policies, please visit our website [ProTradingResearch.com]( where you can find the latest information regarding data collection and use. If you end up visiting [ProTradingResearch.com]( we are strongly committed to protecting your privacy and providing a safe & high-quality online experience for all of our visitors. We understand that you care about how the information you provide to us is used and shared. We have developed a Privacy Policy to inform you of our policies regarding the collection, use, and disclosure of information we receive from users of our website. ProTradingResearch.com operates the Website. This privacy policy has been created to keep you informed about the steps we take once data is acquired. It is regularly updated to meet the needs of a changing technological environment ensuring its relevancy. Our [Privacy Policy]( along with our [Term & Conditions]( governs your use of this site. By using [ProTradingResearch.com]( or by accepting the Terms of Use (via opt-in, checkbox, pop-up, or clicking an email link confirming the same), you agree to be bound by our Terms & Conditions and our Privacy Policy. If you have provided personal, billing, or other voluntarily provided information, you may access, review, and make changes to it via instructions found on the Website or by emailing us at info@em.protradingresearch.com. To manage your receipt of marketing and non-transactional communications, you may unsubscribe by clicking the "unsubscribe" link located on the bottom of any marketing email. By clicking the link you will be taken to a page where you may unsubscribe from future marketing emails. Your change in status may take up to seventy-two hours to be reflected within our system. Emails related to the purchase or delivery of orders are provided automatically – Customers are not able to opt-out of transactional emails. We will try to accommodate any requests related to the management of Personal Information in a timely manner. However, it is not always possible to completely remove or modify information in our databases (for example, if we have a legal obligation to keep it for certain timeframes, for example). If you have any questions, simply reply to this email or visit our website to view our official policies. ProTrading Research 203 N La Salle Street, Suite 2100 | Chicago, IL 60601 [Unsubscribe Here]( Be sure that you receive future email from ProTrading Research – please [whitelist our email address]( with your email provider.